William Forbes

Track

Insider profile

Currently holds a position at Beyond Air Inc

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 37% 8.2% 15.1%
Success rate 53% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Beyond Air Inc Aug. 13, 2018 -
President - Medical, Research and Development and Chief Development Officer Salix Pharmaceuticals Ltd Feb. 2, 2015 - April 1, 2015
Executive Vice President - Research and Development, Chief Medical Officer, Chief Development Officer Salix Pharmaceuticals Ltd Jan. 1, 2010 - Feb. 2, 2015
William Forbes's trades of Heron Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
274.47
Quantity 37,754 +43.9%
Value US$3,797,479
Transaction date
Purchase
Price
19.06
Quantity 23,373 -41.8%
Value US$656,205
Transaction date
Purchase
Price
6.46
Quantity 5,000 +103.0%
Value US$32,300
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-21 2023-11-17
B Purchase
37,754 +43.9%
274.47
US$3,797,479 		37,754 +43.9% 274.47 US$3,797,479
2023-11-20 2023-11-16
B Purchase
6,203 -33.8%
438.36
US$287,644 		6,203 -33.8% 438.36 US$287,644
2023-04-03 2023-03-31
B Purchase
23,373 -41.8%
19.06
US$656,205 		23,373 -41.8% 19.06 US$656,205
2023-03-20 2023-03-17
B Purchase
5,000 +103.0%
6.46
US$32,300 		5,000 +103.0% 6.46 US$32,300